Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Research is underway in the Nuffield Department of Primary Health Care Sciences (Oxford University) to investigate the factors that patients and their family members/friends would take into consideration if a doctor suggested stopping or reducing the patient’s blood pressure (/antihypertensive’) medication.

We currently don’t know which factors (i.e.. side effects, number of tablets, risk of a stroke) these groups prioritize. This survey study aims to fill that research gap, which is important because it could help to improve the patient experience by developing strategies that facilitate and improve the involvement of patients and their family/friends in medication-related decisions.

The study is currently undergoing PPI review and will shortly begin a pilot study.

From early April the survey will be available for all eligible participants, so please check by then if you are interested in taking part!

If you would like any further information, or if you have any questions, please contact Rebecca Garnett: